Aspira Women’s Health (AWH) to Release Earnings on Wednesday

Aspira Women’s Health (NASDAQ:AWH) will announce its earnings results before the market opens on Wednesday, May 15th. Analysts expect the company to announce earnings of ($0.36) per share for the quarter.

Aspira Women’s Health (NASDAQ:AWH) last posted its quarterly earnings data on Thursday, March 28th. The company reported ($0.30) EPS for the quarter, beating analysts’ consensus estimates of ($0.39) by $0.09. Aspira Women’s Health had a negative return on equity of 1,099.32% and a negative net margin of 176.74%. The business had revenue of $2.13 million for the quarter, compared to analyst estimates of $2.70 million. On average, analysts expect Aspira Women’s Health to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Aspira Women’s Health Trading Up 1.0 %

Shares of NASDAQ:AWH opened at $2.98 on Thursday. Aspira Women’s Health has a 12-month low of $2.31 and a 12-month high of $6.75. The stock’s 50-day moving average price is $3.38 and its two-hundred day moving average price is $3.87. The firm has a market cap of $36.77 million, a price-to-earnings ratio of -0.25 and a beta of 1.57.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on AWH shares. StockNews.com started coverage on Aspira Women’s Health in a research note on Thursday. They set a “hold” rating on the stock. Cantor Fitzgerald reiterated a “neutral” rating and issued a $3.30 price target on shares of Aspira Women’s Health in a research note on Wednesday, April 10th.

About Aspira Women’s Health

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering.